FCCM
IRD

First City Capital Management’s Opus Genetics IRD Stock Holding History

First City Capital Management’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.6K Hold
11,836
– – 0.02% 164
2026
Q1 		$53.9K Hold
11,836
– – 0.03% 160
2025
Q4 		$23.8K Buy
+11,836
New +$24K 0.01% 156

First City Capital Management's IRD Position: Q2 2026 in Review

First City Capital Management held its Opus Genetics (IRD) position steady in Q2 2026 at 11,836 shares worth $48.6K. The position accounts for 0.02% of the portfolio, ranked #164.

First City Capital Management first reported a position in IRD in Q4 2025 and has held it in 3 quarters since. The position peaked at $53.9K in Q1 2026. 1 fund tracked by Wall St. Rank holds IRD as of Q2 2026.

  • First City Capital Management held 11,836 shares of Opus Genetics worth $48.6K as of Q2 2026.
  • First City Capital Management left its Opus Genetics share count unchanged in Q2 2026.
  • Opus Genetics made up 0.02% of First City Capital Management's portfolio in Q2 2026, its #164 holding.
  • First City Capital Management first reported a position in Opus Genetics in Q4 2025 and has held it in 3 quarters since.
  • First City Capital Management's Opus Genetics position peaked at $53.9K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on First City Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.